Drug Discovery World

OCTOBER 16, 2023

From the Beatson Institute for Cancer Research in Glasgow, to Edinburgh Drug Discovery in the University of Edinburgh’s Institute for Genetics and Cancer (IGC). At ELRIG’s Scottish Research and Drug Development Forum meeting, DDW’s Diana Spencer provided a snapshot of drug discovery in Scotland.

Drugs 189

Drugs Science Therapies Targeted Protein Degradation 189

Drug Discovery World

MARCH 29, 2023

Regulatory data protection (RDP) period RDP refers to the time when generic drug makers cannot refer to an innovator drug’s data to obtain a marketing authorisation 2.

Clinical Trials 130

Clinical Trials Biosimilars Pharma Companies Production 130

Drug Discovery World

MAY 6, 2024

During the period 2016-2021, the Brazilian, Chinese and Indian markets grew by 11.7%, 6.7% respectively compared to an average market growth of 5.8% for the top five European Union markets and 5.6% for the US market 2. Even before this, however, Amsterdam was established as an important centre for drug development.

Drugs 147

Drugs Science Molecular Biology Clinical Trials 147

Drug Discovery World

SEPTEMBER 28, 2022

Its application in pharma, most commonly in drug discovery, has been steadily growing with global partnerships between tech vendors and pharma companies becoming more commonplace. According to Hampleton Patners’ latest Healthtech M&A market report2, digital health companies raised a total of $57.2

Pharma Companies 130

Pharma Companies Hospitals Clinical Trials Drugs 130

H1 Blog

JULY 30, 2024

This crucial inclusion of diverse populations through enrollment accuracy creates a direct correlation to operational efficiency, allowing for a quicker go-to-market process, a reduction in costly mistakes, and a more robust alignment to overall FDA requirements. billion and taking upwards of 15 years.

FDA 59

FDA Compliance Clinical Trials Pharma Companies 59

Alta Sciences

APRIL 5, 2024

The mini documentary explores transformation in the slow-to-change drug development industry. Leaders from Altasciences dive into the obstacles and inefficiencies of the traditional outsourcing relationship between CROs and drug sponsors, and how Altasciences has broken from tradition to address these challenges.

Drug Development 52

Drug Development Pharma Companies Marketing International 52

Drug Discovery World

AUGUST 4, 2023

Dr Christian K Schneider , Head of Biopharma Excellence at PharmaLex, presents the findings of an industry panel debate on barriers to commercialisation of novel treatments, and the most effective strategies to bring them to market. And I don’t think that’s what’s going to drive the thawing of the financial markets,” Sven noted.

Therapies 130

Therapies Pharma Companies Marketing Treatment 130

Drug Discovery World

FEBRUARY 10, 2023

DDW Editor Reece Armstrong explores the Scandinavian drug discovery sector and speaks to key players about Sweden’s place in the market. Scandinavia represents one of the most exciting but perhaps underrepresented markets for the discovery and development of pharmaceuticals. A good part of half of those are within pharma.

Science 130

Science Drugs Pharmaceutical Companies Pharmaceuticals 130

Drug Discovery World

OCTOBER 4, 2022

Erhardt adds that despite the ever-increasing number of people with AD, there has been an erosion of market value (from $4.2 Several of the large pharma companies have recently re-entered the dementia field. Focused on opportunity . Despite the challenges, Erhardt is clear about the opportunity.

Disease 130

Disease Small Molecule Compound Screening Clinical Development 130

Drug Discovery World

JANUARY 24, 2023

The overall virtual clinical trials market is currently valued at $7.8 ” 4,5,6 Asking the right questions Norstella is a newly formed company that aims to guide life sciences companies through drug development so patients can access therapies quicker. billion, with a projected growth of 14% per annum 1.

Clinical Trials 242

Clinical Trials Trials Drugs Treatment 242

H1 Blog

JULY 5, 2023

The success of drug development and approval relies heavily on the ability to identify diverse patient populations for clinical trials. From trial site feasibility to successful trial recruitment, diversity within a trial population helps ensure the safety and efficacy of drugs that reach the market.

Clinical Trials 52

Clinical Trials Drugs Trials Pharma Companies 52

Drug Discovery World

NOVEMBER 16, 2022

It’s hoped that through this, scientists will be able to better predict how drug molecules perform in the body, leading to expedited drug development and better outcomes for patients. . That means if two pharma companies are trying to grow say a cardiac organoid, they won’t be consistent across the board,” he says. .

Pharma Companies 243

Pharma Companies Science Research Drugs 243

Drug Discovery World

AUGUST 5, 2022

Ian Hollingsworth, Associate Director of product development at Boyds, the global drug development consultancy, explains the benefits to the drug development lifecycle of building strong partnerships with external consultants, and when and how to get the best from them. Why sponsors use external consultants.

Drug Development 130

Drug Development Drugs Pharma Companies International 130

Drug Discovery World

JULY 18, 2022

Troy Groetken of intellectual property and technology law firm McAndrews, Held & Malloy tells Lu Rahman how pharma companies can take this data from where it currently stands (drug design and development) to a more clinical level. Key opportunties. His advice? Up front collection and controlling your data! “As

Clinical Trials 130

Clinical Trials Therapies Pharmaceuticals Science 130

Vial

MARCH 1, 2024

By geographical region, the global CRO services market in 2023 was dominated by North America. Growth factors for this market included the growing size of the pharmaceutical industry, the increasing number of clinical trials , substantial funds dedicated to pharma and biotech R&D, and the growing biosimilars and generics market.

Clinical Trials 52

Clinical Trials Clinical Research Laboratories Trials 52

The Pharma Data

OCTOBER 20, 2020

MD Anderson has historically collaborated with biotechs and pharma companies to conduct cancer therapy research. This is where biotechs are essential to take promising discoveries from the research lab into a product that can be tested, approved and taken to market. But now they’ll be choosing the therapies themselves. .

Clinical Trials 52

Clinical Trials Pharma Companies Therapies Trials 52

PerkinElmer

FEBRUARY 18, 2021

“To lead in product development and partner with customers in solving everyday challenges, we gather information regularly about current practices and future trends,” said Volker Eckelt, PhD, Senior Strategy Leader, PerkinElmer Life Sciences. By a 3:1 margin, PerkinElmer found top Pharma screens for a specific target.

Biochemical Assays 52

Biochemical Assays Drugs Small Molecule Pharma Companies 52

Drug Discovery World

AUGUST 7, 2024

The rest of the pharma R&D system — how drugs are developed, tested, approved, and manufactured — will need to accommodate this vast increase in speed and scale. Pharma R&D has been heading in the wrong direction, becoming progressively less efficient over the last few decades.

Pharma R&D 173

Pharma R&D Clinical Trials Pharma Companies Trials 173

Predictive Oncology

FEBRUARY 7, 2023

That means a lot of wasted effort and resources for drugmakers given that even before a molecule enters Phase I trials, typically five to eight years of development have already been invested in the product. This is going to disrupt the way that drug development is done,” Bush said, by changing the way companies choose drug indications.

Clinical Trials 52

Clinical Trials Pharmaceutical Companies Trials Pharmaceuticals 52

Drug Discovery World

JANUARY 26, 2023

DDW Editor Reece Armstrong takes a look at the pharmaceutical research and development market in 2023 and asks key opinion leaders what challenges and trends will emerge throughout the year. billion showed the pharma giant taking further steps into the oncology market and developing its speciality medicines vaccines portfolio.

Clinical Trials 246

Clinical Trials Drugs Trials Therapies 246

Drug Discovery World

JANUARY 24, 2024

Fibrocor Therapeutics, a developer of novel therapeutics to treat fibrosis, recently appointed Piet Wigerinck as Chief Scientific Advisor. Wigerinck has taken four drugs (Prezista, Olysio, Jyseleca and Rekambys) to market. MT: What technologies are Fibrocor Therapeutics utilising to advance its drug development process?

Small Molecule 147

Small Molecule Research Pharma Companies Disease 147

Drug Discovery World

MAY 7, 2024

It’s doing this by collaborating with companies and providing access to expertise and facilities across 11 specialist research platforms that include things like organoid development, human challenge models, diagnostics, randomised controlled trials, hits to leads and more. They don’t respond to it.

Vaccine 147

Vaccine Pharmaceutical Companies Clinical Trials Trials 147

Drug Discovery World

OCTOBER 7, 2022

Our goal is to take cutting edge innovations from the lab bench to the bedside by translating them into effective treatments and diagnostics for cancer patients; we want to see more of our world-leading research give rise to new drugs, diagnostics and devices to help patients here in the UK and around the world. Tony Hickson.

Pharma Companies 130

Pharma Companies Science Research Drug Development 130

DrugBank

JUNE 27, 2024

Generic drugs are also an interesting case and are common targets for repurposing due to their established safety profiles and long market presence. They also provide a level playing field for academics, biotech companies, and pharma giants to compete on.

Drugs 73

Drugs Pharma Companies Computational Chemistry Clinical Trials 73

The Pharma Data

NOVEMBER 10, 2020

Yohan Tessier, Vice President of Commercial Operations & Strategic Development at Mispro, explained that this is critical in expediting their clients’ time to market. We’re seeing a trend in drug development towards super complex and highly-targeted compounds, which requires researchers to conduct a number of preclinical studies.

Marketing 52

Marketing Pharma Companies Science Research 52

Drug Discovery World

AUGUST 10, 2023

Decreasing the time for market approvals has been the biggest area of focus and progress, not least having witnessed biopharma companies with Covid-19 products being able develop and gain regulatory approval in record time. Structured regulatory data is only partly a technical problem; really the challenge ahead is a business process one.

Pharmaceutical Companies 245

Pharmaceutical Companies Production Science Pharma Companies 245

Drug Discovery World

NOVEMBER 15, 2022

Synthetic libraries for antibody drug discovery . Developing therapeutic antibodies, one of the most successful approaches in drug development, involves identifying and characterising antibodies to be used as treatment against different types of cancers as well as autoimmune and cardiovascular diseases.

DNA 246

DNA Engineering Drugs Vaccine 246

The Connected Lab

APRIL 8, 2020

Prescription drugs have the ability to transform a patient’s life and provides them the opportunity to rid a devastating illness, making the development and approval of these medications urgent and necessary. However, over the last 10 years the path leading to drug approval has become more complicated and expensive.

Pharma Companies 52

Pharma Companies Laboratories FDA Approval Drugs 52

Agency IQ

JULY 12, 2024

In regulation, intended use is defined at 21 CFR 201.128 for drugs and 21 CFR 801.4 for medical devices as “the objective intent of the persons legally responsible for the labeling of” drugs of devices. For drug products, the FDA regulates both product labeling ( 21 CFR 201 ) and promotional labeling ( 21 CFR 202 ).

FDA 40

FDA Regulations Production Science 40

Altus Drug Development

JUNE 28, 2022

This can drastically reduce the time and money it takes for a repositioned drug to reach the market. The formulation and distribution of the drug may be easier to achieve with the current pharmaceutical supply chain infrastructure. There is an increased chance of developing more effective treatments by combining other drugs.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Doctors Production 52

Drug Discovery World

AUGUST 16, 2022

These observations may come to light in the clinic, but these disparities can be attributed to every phase of the drug development pipeline – clinical trials, translational research and, ultimately, drug discovery. . Cancer health disparities and underlying contributing factors .

Research 130

Research Clinical Trials Trials Drug Development 130

Vial

FEBRUARY 19, 2024

By that design, the sum of all parts is designed to solve problems of the current ADCs that are in the market for approval that have quite a bit of a toxicity profile and decreased efficacy potential. Rich McCormick: Drug development can be quite challenging. We have a cell trapper moiety that traps it inside the cell.

Small Molecule 52

Small Molecule Therapies Treatment Science 52

Codon

FEBRUARY 13, 2024

To the question of how to turn this from an academic project into a marketable product, he suggests that a complete phage-testing and synthesis system, or a subscription-like service – with access to the phage-matching algorithms and all the necessary genetic data – could eventually attract major investors.

Therapies 121

Therapies Virus DNA Clinical Trials 121

Drug Discovery World

SEPTEMBER 7, 2022

Every successful therapy brings with it the necessary supporting data that confirms its efficacy and place on the market. In the drug discovery stage, researchers are burdened with the task of combing through vast amounts of datasets in order to find potential targets for their molecule. The challenge of data . Covid-19 .

Research 130

Research Clinical Trials Pharmaceutical Companies Pharma Companies 130

The Pharma Data

DECEMBER 30, 2020

The board will then recommend a “reasonable price” based on the average price in other countries or, if the drug is entering the U.S. market first, based on an evaluation by the independent board members. Four big companies are cited as possible tasty takeover targets for 2021. The company has a market cap of $15.4

Vaccine 52

Vaccine FDA Trials Therapies 52

Drug & Device Law

SEPTEMBER 1, 2023

We observed oral argument the other day in a case that could have a significant impact on potential liability under California tort law for pharma companies and all other innovators. In the end, counsel urged that imposing undue liability would discourage drug development. In Gilead v. Superior Court , No. A165558 (Cal.

Production 64

Production Marketing Pharma Companies FDA Approval 64